Iovance Biotherapeutics, Inc. (IOVA) SEC Filings — 2025
16 SEC filings for Iovance Biotherapeutics, Inc. (IOVA) in 2025.
Filings
- Iovance Revenue Surges, But Restructuring Costs Widen Losses — 10-Q · Nov 6, 2025
- IOVANCE BIOTHERAPEUTICS, INC. Files 8-K — 8-K · Aug 29, 2025
- IOVANCE BIOTHERAPEUTICS, INC. Files 8-K for Material Agreement — 8-K · Aug 22, 2025
- IOVANCE BIOTHERAPEUTICS, INC. Files 8-K — 8-K · Aug 19, 2025
- IOVANCE BIOTHERAPEUTICS Files 8-K on Operations, Personnel Changes — 8-K · Aug 7, 2025
- IOVA's Q2 Net Loss Widens Amid R&D Surge for Amtagvi — 10-Q · Aug 7, 2025
- IOVANCE BIOTHERAPEUTICS: Board and Officer Changes Reported — 8-K · Jul 15, 2025
- IOVANCE BIOTHERAPEUTICS: Board Changes & Executive Compensation Updates — 8-K · Jul 3, 2025
- IOVANCE BIOTHERAPEUTICS: Board & Executive Changes Announced — 8-K · Jun 13, 2025
- IOVANCE BIOTHERAPEUTICS Files 8-K on Security Holder Vote — 8-K · Jun 10, 2025
- IOVANCE BIOTHERAPEUTICS Files 8-K on Financials — 8-K · May 8, 2025
- IOVANCE BIOTHERAPEUTICS Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Iovance Biotherapeutics Files 2025 DEF 14A — DEF 14A · Apr 28, 2025
- IOVANCE BIOTHERAPEUTICS Files 8-K on Financials — 8-K · Feb 27, 2025
- IOVA Files 2024 10-K — 10-K · Feb 27, 2025
- IOVANCE BIOTHERAPEUTICS Files 8-K — 8-K · Feb 10, 2025